SPY390.45+10.09 2.65%
DIA316.61+7.16 2.31%
IXIC13,567.92+375.57 2.85%

--Analyst Actions: Wedbush Cuts Viela Bio to Neutral From Outperform on Horizon Therapeutics Acquisition Offer; Price Target to $53 From $50

· 02/08/2021 01:52

06:43 AM EST, 02/08/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 52.85, Change: 0.00, Percent Change: 0.00